While it is still relatively early in the legislative process, enactment of provisions in the current iteration of S. 1339 would pose significant impacts to entities across the prescription drug distribution chain………………
While it is still relatively early in the legislative process, enactment of provisions in the current iteration of S. 1339 would pose significant impacts to entities across the prescription drug distribution chain………………